NCT01591512终止不适用
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 4
研究概览
简要总结
The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
- •Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
- •Able to understand and willing to provide Informed Consent
排除标准
- •No diagnosis of SCLC
- •Not scheduled to undergo treatment for the diagnosis of SCLC
- •Unable to provide Informed Consent
研究者
研究点 (4)
Loading locations...
相似试验
招募中
不适用
The Indiana Myeloma RegistryPlasma Cell DyscrasiasNCT03616483Indiana University2,500
终止
不适用
A Clinical Investigation of the Oxford® Partial Knee SystemOsteoarthritisNCT00699257Biomet Orthopedics, LLC85
已完成
不适用
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese OriginGlabellar LinesNCT05089357Galderma R&D250
已完成
不适用
Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)CandidemiaNCT01752166T2 Biosystems1,500
已完成
不适用
Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate CancerProstate CancerNCT01574846Orion Corporation, Orion Pharma142
